"10.1371_journal.ppat.1004112","plos pathogens","2014-05-01T00:00:00Z","Emma Hodcroft; Jarrod D Hadfield; Esther Fearnhill; Andrew Phillips; David Dunn; Siobhan O'Shea; Deenan Pillay; Andrew J Leigh Brown; on behalf of the UK HIV Drug Resistance Database and the UK CHIC Study","Institute of Evolutionary Biology, University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom; MRC Clinical Trials Unit Aviation House, London, United Kingdom; Infection and Population Health, University College London, Royal Free Hospital, London, United Kingdom; Department of Infectious Diseases, Kings College London, London, United Kingdom; Research Department of Infection, University College London, London, United Kingdom","Â¶ Membership of the UK HIV Drug Resistance Database and the UK CHIC Study is provided at the end of this paper.","Additional support for the UK HIV Resistance Database is provided by Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, Tibotec (a division of Janssen-Cilag) and Roche. Although some authors have received funding from various commercial organizations for research, travel grants, speaking engagements or consultancy fees, neither those organizations nor the study funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and this does not alter our adherence to all PLOS Pathogens policies on sharing data and materials.","2014","05","Emma Hodcroft","EH",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
